Your browser doesn't support javascript.
loading
Genetic mutation signature for relapse prediction in normal karyotype acute myeloid leukemia.
Han, Lijie; Wu, Jiaying; Lyu, Xiaodong; Yu, Jifeng; Han, Xiaolin; Zhao, Hongmian; Bian, Zhilei; Li, Wei; Fan, Wenjuan; He, Chen; Wang, Weimin; Zhang, Mengmeng; Li, Yafei; Liu, Chao; Sun, Hui; Cao, Haixia; Sang, Li'na; Zhang, Jun; Jiang, Zhongxing; Peng, Jie.
Afiliação
  • Han L; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: hanlijiede@126.com.
  • Wu J; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Lyu X; Central Lab, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Yu J; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Han X; Department of Hematology, the First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
  • Zhao H; Department of Hematology, Huaihe Hospital of Henan University, Kaifeng, China.
  • Bian Z; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Li W; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Fan W; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • He C; Laboratory of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Wang W; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang M; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Li Y; Laboratory of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Liu C; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Sun H; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Cao H; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Sang L; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang J; Department of Oncology, the Second Affiliated Hospital of Guizhou Medical University, Kaili, China.
  • Jiang Z; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: jiangzx@zzu.edu.cn.
  • Peng J; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Department of Oncology, the Second Affiliated Hospital of Guizhou Medical University, Kaili, China. Electronic address: sank44@sina.com.
Exp Hematol ; 128: 67-76, 2023 12.
Article em En | MEDLINE | ID: mdl-37739208
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Nucleofosmina Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Nucleofosmina Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article